<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="utf-8">
  <meta name="viewport" content="width=device-width, initial-scale=1">
  <title>Zopiclone - Medications - Offline Clinical Reference</title>
  <link rel="stylesheet" href="../style.css">
</head>
<body>
  <div class="topbar">
    <div class="topbar-inner">
      <span class="pill"><strong>Zopiclone</strong></span>
      <span class="spacer"></span>
      <div class="nav-btns">
        <a class="btn small" href="../index.html">Home</a>
        <a class="btn small" href="../medications.html">Back to Medications</a>
      </div>
    </div>
  </div>

  <main class="wrap">
    <section class="section">
      <div class="kicker">Neuro / Psych</div>
      <h1>Zopiclone</h1>

      <div class="content">
        <h3>Stocked on board</h3>
        <ul>
          <li>Zopiclone 7.5mg Tablets</li>
        </ul>

        <div class="rule"></div>

        <h3>Adult dosing</h3>
        <ul>
          <li><strong>Insomnia (short-term treatment)</strong>
            <ul>
              <li>7.5 mg PO at bedtime (taken immediately before bed or after getting into bed)</li>
              <li>Use lowest effective dose for shortest duration (typically 7–10 days, maximum 4 weeks)</li>
            </ul>
          </li>
          <li><strong>Older adults (≥65 years) or debilitated patients</strong>
            <ul>
              <li>Initial: 3.75 mg PO at bedtime (half tablet if scored, or use lower-strength formulation if available)</li>
              <li>May increase to 7.5 mg if needed and tolerated, but use caution</li>
            </ul>
          </li>
          <li><strong>Hepatic impairment</strong>
            <ul>
              <li>Start with 3.75 mg; avoid in severe hepatic impairment</li>
            </ul>
          </li>
          <li><strong>Renal impairment</strong>
            <ul>
              <li>Mild-moderate: no dose adjustment usually needed; use caution</li>
              <li>Severe (CrCl &lt;10 mL/min) or dialysis: start with 3.75 mg and monitor closely</li>
            </ul>
          </li>
        </ul>

        <div class="rule"></div>

        <h3>Indications</h3>
        <ul>
          <li>Short-term treatment of insomnia (difficulty falling asleep, frequent nocturnal awakenings, early morning awakening)</li>
          <li>Transient insomnia due to situational stress or environmental factors (e.g., shift work, time zone changes)</li>
          <li>NOTE: Use only for short-term management onboard; reassess need frequently and discontinue as soon as feasible</li>
        </ul>

        <div class="rule"></div>

        <h3>Contraindications / cautions</h3>
        <ul>
          <li>Hypersensitivity to zopiclone or other cyclopyrrolones</li>
          <li>Severe respiratory insufficiency, sleep apnea syndrome, myasthenia gravis (risk of respiratory depression)</li>
          <li>Severe hepatic impairment (risk of encephalopathy)</li>
          <li>Pregnancy and breastfeeding: avoid (sedation and withdrawal risk in newborn)</li>
          <li>History of substance abuse or dependence (zopiclone has abuse potential and risk of dependence with prolonged use)</li>
          <li>CNS depression: avoid with alcohol, opioids, benzodiazepines, or other sedatives (additive effects)</li>
          <li>Complex sleep behaviors (sleepwalking, sleep-driving, sleep-eating): discontinue if occurs</li>
          <li>Depression/suicidal ideation: may worsen depression; monitor closely</li>
          <li>Older adults: increased fall risk, confusion, cognitive impairment; use lowest dose</li>
        </ul>

        <div class="rule"></div>

        <h3>Adverse effects</h3>
        <ul>
          <li>Bitter or metallic taste (very common; may persist into next day)</li>
          <li>Drowsiness, dizziness, headache</li>
          <li>Dry mouth, nausea</li>
          <li>Daytime sedation, impaired coordination (especially if insufficient sleep time or with alcohol/other CNS depressants)</li>
          <li>Amnesia, confusion (especially in older adults)</li>
          <li>Complex sleep behaviors (sleepwalking, sleep-driving) — rare but serious</li>
          <li>Dependence and withdrawal symptoms with prolonged use (anxiety, rebound insomnia, tremor, sweating)</li>
          <li>Respiratory depression (rare, more likely with overdose or concurrent CNS depressants)</li>
        </ul>

        <div class="rule"></div>

        <h3>Preparation &amp; administration</h3>
        <ul>
          <li>PO tablet; take immediately before bedtime or after getting into bed</li>
          <li>Ensure patient has 7–8 hours available for sleep (risk of daytime impairment if insufficient sleep time)</li>
          <li>Avoid alcohol and other CNS depressants</li>
          <li>Do not take with or immediately after a heavy or high-fat meal (may delay onset)</li>
          <li>Short-term use only (7–10 days; maximum 4 weeks); reassess frequently and discontinue as soon as possible</li>
          <li>If used for more than a few nights, taper dose gradually to avoid rebound insomnia and withdrawal</li>
          <li>Counsel on sleep hygiene: avoid caffeine/stimulants before bed, maintain regular sleep schedule, minimize screen time, create restful environment</li>
        </ul>

        <div class="rule"></div>

        <h3>Monitoring</h3>
        <ul>
          <li>Sleep quality and duration; reassess need for continued therapy daily</li>
          <li>Daytime sedation, cognitive impairment, coordination (especially before watchkeeping duties)</li>
          <li>Fall risk (especially in older adults or those on other sedatives)</li>
          <li>Complex sleep behaviors: question patient about any unusual nighttime activities</li>
          <li>Signs of dependence or misuse: escalating dose requests, preoccupation with medication</li>
          <li>Mood changes, depression, suicidal ideation (especially in patients with psychiatric history)</li>
        </ul>

        <div class="rule"></div>

        <h3>At-sea considerations</h3>
        <ul>
          <li>Operational safety: zopiclone causes significant sedation—patient must have 7–8 hours off-duty after dose; do NOT use before watchkeeping or critical operations</li>
          <li>First dose should be given when patient has full night off duty to assess individual response (residual morning sedation varies)</li>
          <li>Use only for transient insomnia; reassess daily and stop as soon as sleep normalizes</li>
          <li>Non-pharmacologic approaches first: optimize sleep environment (noise reduction, darkness, temperature), limit caffeine, encourage regular sleep schedule, address underlying anxiety/stress</li>
          <li>Avoid in patients with known sleep apnea or loud snoring unless already established on therapy and monitored</li>
          <li>Document indication, dose, start date, planned duration, and nightly use clearly; limit supply to avoid prolonged use</li>
          <li>If patient requests continuation beyond 7–10 days, reassess for underlying sleep disorder, mood disorder, or medication side effects and consider evacuation for formal evaluation</li>
          <li>Taper if used for &gt;3–5 consecutive nights: reduce dose by half for 2–3 nights before stopping to minimize rebound insomnia</li>
        </ul>

        <div class="rule"></div>

        <h3>Online-only references</h3>
        <ul>
          <li>Health Canada product monograph (zopiclone tablets): <a href="https://pdf.hres.ca/dpd_pm/00067931.PDF" target="_blank" rel="noopener">https://pdf.hres.ca/dpd_pm/00067931.PDF</a></li>
          <li>Health Canada product monograph (Imovane – zopiclone reference): <a href="https://pdf.hres.ca/dpd_pm/00027965.PDF" target="_blank" rel="noopener">https://pdf.hres.ca/dpd_pm/00027965.PDF</a></li>
          <li>Medscape reference (zopiclone): <a href="https://reference.medscape.com/drug/imovane-zopiclone-342055" target="_blank" rel="noopener">https://reference.medscape.com/drug/imovane-zopiclone-342055</a></li>
        </ul>
      </div>

      <p class="foot">
        Verify dosing and indications against current clinical guidelines.
      </p>
    </section>
  </main>
</body>
</html>
